首页> 外文期刊>Fresenius environmental bulletin >EVALUATION OF THE IN VITRO AND IN VIVO EFFECTS OF THE ETHANOLIC LYOPHILIZED EXTRACT OBTAINED FROM PHOLIOTA AURIVELLA MUSHROOM ON CCI_4-INDUCED TOXICITY IN RATS
【24h】

EVALUATION OF THE IN VITRO AND IN VIVO EFFECTS OF THE ETHANOLIC LYOPHILIZED EXTRACT OBTAINED FROM PHOLIOTA AURIVELLA MUSHROOM ON CCI_4-INDUCED TOXICITY IN RATS

机译:从胆管乳蛋白酶中获得的乙醇冻干提取物对大鼠CCI_4诱导毒性的乙醇冻干提取物的体外和体内效应的评价

获取原文
       

摘要

The aim of this study was to evaluate Pholiota aurivella extract5 s chemical and mineral composition, total antioxidant capacity, histopathological changes in liver and kidney, as well as its possible protective/harmful role against carbon tetrachloride (CCl_4)-induced oxidative stress in rats. After the toxicity test, twenty four rats were divided into four experimental groups : Control, CCl_4, CCl_4+P. aurivella (100 mg/kg, extract) and CCl_4+P. aurivella (500 mg/kg, extract) groups. Some biochemical parameters such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) in serum, malondialdehyde (MDA) and antioxidant defense system (ADS) constituents such as reduced glutathione (GSH) levels, glutathione reductase (GR), glutathione S-transferase (GST), superoxide dis- mutase (SOD), glutathione peroxidase (GPx) and catalase (CAT) activities in the liver, brain and kidney tissues, histopathological changes in liver and kidney of rats were observed. P.aurivella extract was rich in phenolic (p-coumaric and proto- catechuic acids) and fatty acid (linoleic, oleic and palmitic acids) compounds and high level of Arsenic. In vivo studies revealed that P.aurivella extract suppressed the levels of ADS enzymes and increased the MDA content and AST, ALT and LDH in treated groups. According to histopathological investigation, liver and kidney revealed severe histopathological changes both in CCU group and P.aurivella - treated groups. These results have shown that oral administration of P.aurivella extract caused a significant toxic effects in rats. Therefore, in the context of the data obtained from this study the P.aurivella could not be regarded as a safe food source.
机译:本研究的目的是评估肝脏和肾脏的总抗氧化能力,总抗氧化能力,组织病理学变化,以及对大鼠氧化应激的氧化胁迫的可能保护/有害的作用。毒性试验后,将二十四只大鼠分为四组:对照,CCL_4,CCL_4 + P. Aurivella(100mg / kg,提取物)和ccl_4 + p。 Aurivella(500 mg / kg,提取物)组。一些生化参数,如天冬氨酸氨基转移酶(AST),丙氨酸氨基转移酶(ALT),血清中乳酸脱氢酶(LDH),丙酸甲醚(MDA)和抗氧化剂防御系统(ADS)成分,如降低的谷胱甘肽(GSH)水平,谷胱甘肽还原酶(GR ),观察谷胱甘肽S-转移酶(GST),超氧化物过氧化物酶(GPX)和过氧化氢酶(GPX)和过氧化氢酶(CAT)活性,肝脏,脑和肾组织,肝脏和肾脏的组织病理学变化。 p.aurivella提取物富含酚醛(p-作用和原酸)和脂肪酸(亚油,油酸和棕榈酸)化合物和高水平的砷。体内研究表明,P.Aurivella提取物抑制了ADS酶的水平,并在治疗组中增加了MDA含量和AST,ALT和LDH。根据组织病理学调查,肝肾揭示CCU组和P.Aurivella治疗组的严重组织病理学变化。这些结果表明,口服施用p.aurivella提取物在大鼠中引起显着的毒性作用。因此,在从该研究获得的数据的背景下,P.Aurivella不能被视为安全的食物来源。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号